Four‐year drug survival of apremilast in patients with psoriasis
The Journal of Dermatology · 2023
DOI: 10.1111/1346-8138.16766 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Dermatology, 2023. Verfasst von Megumi Kishimoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Jichi Medical University, Tochigi, Japan. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Psoriasis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
This real‐world study at a single academic center retrospectively examined the drug survival of apremilast for patients with psoriasis. Retrospective information was extracted from the medical records of patients with psoriasis treated with apremilast at the Department of Dermatology, Jichi Medical University Hospital, between March 1, 2017, and June 31, 2021. In total, 281 patients were included in this study. Of these patients, 22% had psoriatic arthritis and 57% had a history of prior systemic treatment, including biologics, before the initiation of apremilast. The 1‐, 2‐, 3‐, and 4‐year drug survival rates were 54%, 41%, 32%, and 30%, respectively. Cox regression analysis revealed that sex, duration of plaque psoriasis (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Jichi Medical University, Tochigi, Japan.
ORCID-Profile: Megumi Kishimoto, Mayumi Komine, Koji Kamiya
Zitieren
APA
Kishimoto, M., Komine, M., Kamiya, K., Sugai, J., Kuwahara, A., & Ohtsuki, M. (2023). Four‐year drug survival of apremilast in patients with psoriasis. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16766
Vancouver
Kishimoto M, Komine M, Kamiya K, Sugai J, Kuwahara A, Ohtsuki M. Four‐year drug survival of apremilast in patients with psoriasis. The Journal of Dermatology. 2023. doi:10.1111/1346-8138.16766
BibTeX
@article{Kishimoto2023,
author = {Kishimoto, Megumi and Komine, Mayumi and Kamiya, Koji and Sugai, Junichi and Kuwahara, Aya and Ohtsuki, Mamitaro},
title = {Four‐year drug survival of apremilast in patients with psoriasis},
journal = {The Journal of Dermatology},
year = {2023},
doi = {10.1111/1346-8138.16766}
}
EUVIMED